Top Markets
Coin of the day
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.

Poniard Pharmaceuticals, Inc.

PARD
Rang in aandelen #42764
Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the... Poniard Pharmaceuticals, Inc. is a biopharmaceutical company dedicated to the discovery and market introduction of cancer treatments. Its flagship product candidate, Picoplatin, is a platinum-based therapy targeting various cancer types, such as small cell lung, colorectal, prostate, and ovarian cancers. The company has advanced Picoplatin through several clinical stages, including a pivotal Phase III SPEAR trial for small cell lung cancer patients in a second-line treatment setting. Furthermore, Phase II studies investigated Picoplatin as an initial therapy for metastatic colorectal cancer and hormone-refractory prostate cancer. An early-stage Phase I trial also examined an oral formulation of Picoplatin for solid tumors. Founded in 1984 as NeoRx Corporation, the company rebranded to Poniard Pharmaceuticals, Inc. in September 2006 and operates from its base in Seattle, Washington.
Aandeelprijs
$0.0001
Laatst gesynchroniseerd: 2026-08-11
Marktkapitalisatie
$150.00
Verandering (1 dag)
0.00%
Verandering (1 jaar)
0.00%
Land
US
Handel Poniard Pharmaceuticals, Inc. (PARD)

Categorie

Prijs PARD met de marktkapitalisatie van B
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
PARD
$0.0001
Marktkapitalisatie van Poniard Pharmaceuticals, Inc.(PARD)
Marktkapitalisatie: $150.00
Vanaf August 2026 heeft Poniard Pharmaceuticals, Inc. een marktkapitalisatie van $150.00. Dit maakt Poniard Pharmaceuticals, Inc. volgens onze gegevens het 42764th meest waardevolle bedrijf ter wereld op basis van marktkapitalisatie. De marktkapitalisatie is de totale marktwaarde van alle uitstaande aandelen van een beursgenoteerd bedrijf en wordt vaak gebruikt om de waarde van een bedrijf te meten.
Marktkapitalisatiegeschiedenis van Poniard Pharmaceuticals, Inc. van 1988 tot 2026
PARD vergeleken met de top 5 populairste stocks
Prijs voor PARD Aandeel B Marktkapitalisatie van B uitslagen
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$3,588,906 $150.00
$5.383T +3,588,906,306,566.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,948,927 $150.00
$4.423T +2,948,927,469,058.67%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,773,580 $150.00
$4.160T +2,773,579,599,288.00%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$2,442,214 $150.00
$3.663T +2,442,213,891,233.33%
Poniard Pharmaceuticals, Inc. Poniard Pharmaceuticals, Inc.
$1,927,486 $150.00
$2.891T +1,927,485,863,500.00%